Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

6.71

-0.16 (-2.33%)

Oct 13, 2026, 4:00 PM EDT - Market closed

Gyre Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	711	642	1,038	1,967	-
Market Cap Growth	-1.59%	-38.21%	-47.22%	-	-
Enterprise Value	640	618	1,050	1,946	-
Last Close Price	6.71	7.06	12.10	25.69	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	-	127.65	85.93	-	-
Forward PE	-	32.84	-	-	-
PS Ratio	6.48	5.50	9.82	17.34	-
PB Ratio	6.59	4.51	10.55	25.07	-
P/TBV Ratio	6.88	6.43	16.85	-	-
P/FCF Ratio	-	-	-	113.23	-
P/OCF Ratio	-	635.33	-	75.99	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
EV/Sales Ratio	5.83	5.30	9.93	17.15	-
EV/EBITDA Ratio	-	44.13	58.96	95.72	-
EV/EBIT Ratio	-	53.81	64.73	101.27	-
EV/FCF Ratio	-	-	-	111.99	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	0.02	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	-	0.06	0.09	0.02	0.06
Debt / FCF Ratio	-	-	-	0.02	0.11
Net Debt / Equity Ratio	-0.43	-0.36	-0.25	-0.42	-0.34
Net Debt / EBITDA Ratio	5.88	-3.67	-1.41	-1.63	-2.38
Net Debt / FCF Ratio	11.69	286.03	4.21	-1.90	-4.32
Asset Turnover	0.62	0.80	0.87	1.13	-
Inventory Turnover	0.67	0.66	0.73	0.89	-
Quick Ratio	3.59	4.58	2.64	2.49	3.33
Current Ratio	4.26	5.60	3.32	2.85	4.06
Return on Equity (ROE)	-17.44%	8.21%	20.24%	-113.45%	-
Return on Assets (ROA)	-5.42%	4.93%	8.38%	11.93%	-
Return on Invested Capital (ROIC)	-16.81%	9.58%	21.08%	41.30%	8.85%
Return on Capital Employed (ROCE)	-8.90%	7.80%	15.30%	19.90%	12.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Earnings Yield	-2.80%	0.78%	1.16%	-4.72%	-
FCF Yield	-0.86%	-0.03%	-0.57%	0.88%	-
Buyback Yield / Dilution	1.16%	-0.87%	-55.39%	13.02%	-

SEC Filings: 10-K · 10-Q